Latest / The Pivot Podcast with Fexingo: How Businesses Change Direction and Survive Disruption
How Pfizer Pivoted to mRNA and Reinvented Vaccines
In this episode of The Pivot Podcast, Lucas and Luna explore how Pfizer transformed from a traditional pharmaceutical giant into a pioneer of mRNA technology. The conversation centers on Pfizer's pivotal 2018 acquisition of BioNTech's mRNA platform, a bet that would redefine vaccine development during the COVID-19 pandemic. But the story goes deeper: how Pfizer's leadership recognized the potential of mRNA years before the crisis, invested $185 million in a risky partnership, and built a manufacturing infrastructure that slashed vaccine production from years to months. Lucas…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.